Last reviewed · How we verify
Two doses of Pentamidine
At a glance
| Generic name | Two doses of Pentamidine |
|---|---|
| Also known as | Pentamidine (7mg/kg) in two weekly applications. |
| Sponsor | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis (PHASE2)
- A Pilot, Dose Escalating Study on VLX103 in Moderate Alcoholic Steatohepatitis (PHASE1)
- Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation (PHASE1, PHASE2)
- A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment (PHASE1, PHASE2)
- A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy (PHASE1, PHASE2)
- A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: